249 related articles for article (PubMed ID: 9465949)
1. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
[TBL] [Abstract][Full Text] [Related]
2. Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.
Ohnishi T; Noguchi S; Murakami N; Tajiri J; Harao M; Kawamoto H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S
Radiology; 1994 Mar; 190(3):857-62. PubMed ID: 8115640
[TBL] [Abstract][Full Text] [Related]
3. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
Hosten N; Schörner W; Lietz A; Wenzel KW
Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813
[TBL] [Abstract][Full Text] [Related]
4. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
[TBL] [Abstract][Full Text] [Related]
5. Graves ophthalmopathy: MR imaging of the orbits.
Hosten N; Sander B; Cordes M; Schubert CJ; Schörner W; Felix R
Radiology; 1989 Sep; 172(3):759-62. PubMed ID: 2772184
[TBL] [Abstract][Full Text] [Related]
6. Graves ophthalmopathy: role of MR imaging in radiation therapy.
Just M; Kahaly G; Higer HP; Rösler HP; Kutzner J; Beyer J; Thelen M
Radiology; 1991 Apr; 179(1):187-90. PubMed ID: 2006276
[TBL] [Abstract][Full Text] [Related]
7. [Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].
Hosten N; Cordes M; Sander B; Schörner W; Wenzel KW; Felix R
Rofo; 1990 Apr; 152(4):388-92. PubMed ID: 2160096
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
[TBL] [Abstract][Full Text] [Related]
9. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
Utech CI; Khatibnia U; Winter PF; Wulle KG
Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
[TBL] [Abstract][Full Text] [Related]
10. [Computed tomographic volumetry of the orbit in endocrine orbitopathy].
Krahe T; Schlolaut KH; Poss T; Trier HG; Lackner K
Rofo; 1989 Nov; 151(5):597-601. PubMed ID: 2554416
[TBL] [Abstract][Full Text] [Related]
11. Graves' disease of the orbit.
Weber AL; Dallow RL; Sabates NR
Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
[TBL] [Abstract][Full Text] [Related]
12. Quantitative CT of the orbit in Graves' disease.
Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I
Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341
[TBL] [Abstract][Full Text] [Related]
13. [Sonography of the retrobulbar space in autoimmune hyperthyroidism of the Basedow type].
Schillings S; Wagner J; Franzen W; Wildmeister W
Z Gesamte Inn Med; 1990 Nov; 45(22):678-83. PubMed ID: 2099028
[TBL] [Abstract][Full Text] [Related]
14. [Results of nuclear magnetic resonance tomography studies in endocrine orbitopathy].
Pedrosa P; Pfannenstiel P; Just M; Higer HP; Utech C; Brederhoff J; Wulle KG
Klin Monbl Augenheilkd; 1988 Aug; 193(2):169-73. PubMed ID: 3184751
[TBL] [Abstract][Full Text] [Related]
15. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography.
Yamamoto K; Itoh K; Yoshida S; Saito K; Sakamoto Y; Matsuda A; Saito T; Kuzuya T
Endocrinol Jpn; 1979 Apr; 26(2):255-61. PubMed ID: 582582
[TBL] [Abstract][Full Text] [Related]
16. Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.
Nakahara H; Noguchi S; Murakami N; Morita M; Tamaru M; Ohnishi T; Hoshi H; Jinnouchi S; Nagamachi S; Futami S
Radiology; 1995 Sep; 196(3):857-62. PubMed ID: 7644656
[TBL] [Abstract][Full Text] [Related]
17. Graves orbitopathy: correlation of CT and clinical findings.
Nugent RA; Belkin RI; Neigel JM; Rootman J; Robertson WD; Spinelli J; Graeb DA
Radiology; 1990 Dec; 177(3):675-82. PubMed ID: 2243967
[TBL] [Abstract][Full Text] [Related]
18. Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy.
Kahaly G; Diaz M; Just M; Beyer J; Lieb W
Thyroid; 1995 Apr; 5(2):107-11. PubMed ID: 7647569
[TBL] [Abstract][Full Text] [Related]
19. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
20. Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.
Feldon SE; Lee CP; Muramatsu SK; Weiner JM
Arch Ophthalmol; 1985 Feb; 103(2):213-5. PubMed ID: 3838463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
